The Mantle Cell Lymphoma ( Mcl ) - 1697 Words

Mantle Cell Lymphoma (MCL) Non-Hodgkin’s lymphoma are cancers that do not originate in white blood cells but rather elsewhere in the lymphatic system such as a lymph node, bone marrow, spleen, or thymus and are categorized into which cells it effects such as B-cell, T-cell and NK-cells (MD Cancer Center, 2015). B-cell lymphoma represents the majority of non-Hodgkin Lymphoma (85%) and of these Mantle Cell Lymphoma (MCL) represents about 5% of the type of B-cell lymphoma (American Cancer Society, 2015). According to the American Cancer Society, MCL is rare, common in men in their later years (60s) and is a slow growing cancer (2015). The gentleman presented in this case study has been diagnosed with MCL; his medical findings, plan of care and treatment will be discussed and correlated with today’s guidelines and practices for the MCL population in making his cancer history. Case Study Subject GB is a very pleasant individual who was admitted for chemotherapy. GB is a 41 y/o Hispanic male with an oncology diagnosis of MCL. The expected duration of this admission is 14 days for his high-dose chemotherapy for MCL, cycle #3A of R-CODOX –M regimen, of Chemotherapy. GB has been placed on a regular diet; current weight: 66kg; height: 169 cm; BMI: 23 (normal weight range); Braden score: 22 (not a fall risk, continue to reassess/monitor); placed on chemotherapy precautions and has a central line-triple lumen. GB’s wife has been staying with him at night and keeps him company when sheShow MoreRelatedLymphoma, Lymphoma And Non Hodgkin Lymphoma1151 Words   |  5 PagesLymphoma is a general term for many similar subtypes of cancers that come from a white blood cell called a â€Å"lymphocyte.† Lymphoma has two major categories: Hodgkin lymphoma and non-Hodgkin lymphoma. Mantle cell lymphoma is merely 1 of 70 different types of NHL. US National Library of Medicin e National Institutes of Health 2008. Lymphatic cancer, also known as Lymphoma, is a cancer of the body’s lymph nodes. Records show MCL occurs in about 20,000 to 200,000 cases annually in the United States; 20Read MoreA Short Note On Non Hodgkin s Lymphoma1916 Words   |  8 PagesNon-Hodgkin’s lymphoma is one of the most common types of cancers in the United States that affect mostly older adults. The American Cancer Society estimates that 72,580 people in the Unites States will be diagnosed with the disease just in the year 2016 alone. Of that number, there are about 20,150 people expected to die from the disease. There is also a 2% chance of people in the United States developing the disease (American cancer society, n.d.). There have been many researches done about theRead MoreCase Study Of DLBCA1185 Words   |  5 PagesDiscussion Non-Hodgkin lymphoma (NHL) is the fifth most common cancer type, worldwide. DLBCL is the most common form of NHL [104, 105]. DLBCL is a heterogeneous group of disease, in regards to pathology and clinical genetics characteristics. The heterogeneity arise, due to dysregulation in different stage of B-cell development, regulated by different transcription factors such as B-cell lymphoma 6 (BCL-6)[106-108]. Due to this clinical and biological diversity, DLBCL is categorized into two commonRead MoreSynthesis And Biological Use As Potential Anticancer Agents1841 Words   |  8 Pagescancers in China since 1984. It was recently found to be capable of inducing apoptosis in human colon carcinoma, hepatoma and glioblastoma cells by way of an elusive mechanism.1 Norcantatharidins and their analogues are synthetic anticancer agents which have been used in various different procedures for the inducing growth arrest and apoptosis of tumour cells and also provide therapeutic and adjuvant therap eutic applications in the treatment of cancer agents.2 This report will discuss the various